366 related articles for article (PubMed ID: 15364464)
1. Waning immunity and subclinical measles infections in England.
Glass K; Grenfell BT
Vaccine; 2004 Sep; 22(29-30):4110-6. PubMed ID: 15364464
[TBL] [Abstract][Full Text] [Related]
2. Study of antibody titres after measles vaccination: fever within 7 days of vaccination and efficacy of booster doses.
Egami T; Egami K; Tanoue A
Arch Dis Child; 2008 Apr; 93(4):319-20. PubMed ID: 17488762
[TBL] [Abstract][Full Text] [Related]
3. Girls may have lower levels of maternal measles antibodies and higher risk of subclinical measles infection before the age of measles vaccination.
Martins C; Bale C; Garly ML; Rodrigues A; Lisse IM; Andersen A; Eriksson M; Benn CS; Whittle H; Aaby P
Vaccine; 2009 Aug; 27(38):5220-5. PubMed ID: 19596409
[TBL] [Abstract][Full Text] [Related]
4. Duration of immunity following immunization with live measles vaccine: 15 years of observation in Zhejiang Province, China.
Dai B; Chen ZH; Liu QC; Wu T; Guo CY; Wang XZ; Fang HH; Xiang YZ
Bull World Health Organ; 1991; 69(4):415-23. PubMed ID: 1934235
[TBL] [Abstract][Full Text] [Related]
5. Haemagglutination inhibition antibody levels one year after natural measles infection and vaccination.
Eghafona NO; Ahmad AA; Ezeokoli CD; Emejuaiwe SO
Microbios; 1991; 67(274):33-6. PubMed ID: 1758308
[TBL] [Abstract][Full Text] [Related]
6. [Study on the subclinical infection of the recipients of measles vaccine].
Wu T; Wang SL; Xiang YZ
Zhonghua Liu Xing Bing Xue Za Zhi; 1996 Apr; 17(2):70-2. PubMed ID: 8758397
[TBL] [Abstract][Full Text] [Related]
7. Experimental measles. II. Infection and immunity in the rhesus macaque.
Zhu YD; Heath J; Collins J; Greene T; Antipa L; Rota P; Bellini W; McChesney M
Virology; 1997 Jun; 233(1):85-92. PubMed ID: 9229928
[TBL] [Abstract][Full Text] [Related]
8. Measles active and passive immunity in a worldwide perspective.
Black FL
Prog Med Virol; 1989; 36():1-33. PubMed ID: 2685909
[TBL] [Abstract][Full Text] [Related]
9. Waning antibodies in measles and rubella vaccinees--a longitudinal study.
Kremer JR; Schneider F; Muller CP
Vaccine; 2006 Mar; 24(14):2594-601. PubMed ID: 16427163
[TBL] [Abstract][Full Text] [Related]
10. Measles seroepidemiology among adolescents and young adults: response to revaccination.
Saffar MJ; Alraza-Amiri M; Ajami A; Baba-Mahmoodi F; Khalilian AR; Vahidshahi C; Shamsizadeh A
East Mediterr Health J; 2006 Sep; 12(5):573-81. PubMed ID: 17333796
[TBL] [Abstract][Full Text] [Related]
11. Measles vaccine efficacy: influence of age at vaccination vs. duration of time since vaccination.
Shelton JD; Jacobson JE; Orenstein WA; Schulz KF; Donnell HD
Pediatrics; 1978 Dec; 62(6):961-4. PubMed ID: 733424
[TBL] [Abstract][Full Text] [Related]
12. Population immunity to measles in the United States, 1999.
Hutchins SS; Bellini WJ; Coronado V; Jiles R; Wooten K; Deladisma A
J Infect Dis; 2004 May; 189 Suppl 1():S91-7. PubMed ID: 15106096
[TBL] [Abstract][Full Text] [Related]
13. [The epidemiological efficacy of mass vaccination against measles among the troops].
Sibilev VI; Shevtsova VA; Tiasto EA
Voen Med Zh; 1994 Feb; (2):50-1, 80. PubMed ID: 8165796
[TBL] [Abstract][Full Text] [Related]
14. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
[TBL] [Abstract][Full Text] [Related]
15. Estimation of the time-dependent vaccine efficacy from a measles epidemic.
Eichner M; Diebner HH; Schubert C; Kreth HW; Dietz K
Stat Med; 2002 Aug; 21(16):2355-68. PubMed ID: 12210620
[TBL] [Abstract][Full Text] [Related]
16. Measles vaccination effectiveness among children under 5 years of age in Kampala, Uganda.
Mupere E; Karamagi C; Zirembuzi G; Grabowsky M; de Swart RL; Nanyunja M; Mayanja H
Vaccine; 2006 May; 24(19):4111-5. PubMed ID: 16554111
[TBL] [Abstract][Full Text] [Related]
17. Distinguishing between primary measles infection and vaccine failure reinfection by IgG avidity assay.
Hamkar R; Mahmoodi M; Nategh R; Jelyani KN; Eslami MB; Mohktari-Azad T
East Mediterr Health J; 2006 Nov; 12(6):775-82. PubMed ID: 17333822
[TBL] [Abstract][Full Text] [Related]
18. Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination.
Dilraj A; Sukhoo R; Cutts FT; Bennett JV
Vaccine; 2007 May; 25(21):4170-4. PubMed ID: 17408818
[TBL] [Abstract][Full Text] [Related]
19. [The state of measles immunity and the success quota of measles vaccination in Basle nursery and elementary school pupils].
Just M; Baechlin A; Berger R; Bürgin-Wolff A
Schweiz Med Wochenschr; 1980 Apr; 110(14):528-30. PubMed ID: 7375902
[TBL] [Abstract][Full Text] [Related]
20. Measles cases in highly vaccinated population of Novosibirsk, Russia, 2000-2005.
Atrasheuskaya AV; Kulak MV; Neverov AA; Rubin S; Ignatyev GM
Vaccine; 2008 Apr; 26(17):2111-8. PubMed ID: 18343536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
